TNC and colon carcinoma: To address the pharmacology behaviour of ST2146 and to evaluate its ability to localise at the tumour mass, comparative biodistribution studies of 125I-labelled ST2146, BC4, BC2 and ST1897 were performed in nude mice grafted with tenascin expressing human colon carcinoma HT29.